Team:Paris/August 17
From 2008.igem.org
(Difference between revisions)
(→Analysis of the transformation we did yesterday) |
|||
Line 49: | Line 49: | ||
|No | |No | ||
|OK | |OK | ||
+ | |} | ||
+ | |||
+ | ==='''PCR Screening'''=== | ||
+ | [[Team:Paris/Protocols#PCR Screening| Protocol]] | ||
+ | |||
+ | ==='''Minipreps'''=== | ||
+ | {|border="1" style="text-align: center" | ||
+ | |'''Miniprep Name''' | ||
+ | |'''Ligation name''' | ||
+ | |''Antibio''' | ||
+ | |'''Biobricks''' | ||
+ | |'''Description''' | ||
+ | |- | ||
+ | |MP161.1 | ||
+ | |L150.1 | ||
+ | |rowspan="3" |Amp | ||
+ | |rowspan="3" |[[Image:part_icon_regulatory.png]][[Image:Part_icon_rbs.png]][[Image:icon_coding.png]][[Image:Part_icon_rbs.png]][[Image:Part_icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]] | ||
+ | |rowspan="3" |pLas - rbs-TetR-GFP tripart | ||
+ | |- | ||
+ | |MP161.2 | ||
+ | |L150.2 | ||
+ | |- | ||
+ | |MP161.3 | ||
+ | |L150.3 | ||
+ | |- | ||
+ | |MP162.1 | ||
+ | |L151.1 | ||
+ | |rowspan="3" |Kan | ||
+ | |rowspan="3" |[[Image:Part_icon_rbs.png]][[Image:icon_coding.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]] | ||
+ | |rowspan="3" |rbs-LasR - Double terminator | ||
+ | |- | ||
+ | |MP162.2 | ||
+ | |L151.2 | ||
+ | |- | ||
+ | |MP162.3 | ||
+ | |L152.3 | ||
|} | |} |
Revision as of 14:09, 17 August 2008
Analysis of the transformation we did yesterday
PCR ScreeningMinipreps |